慢性疾病中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗抗体反应受损：一项真实世界分析 - Suppr

Suppr

超能文献

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis.

作者信息

Liao Shu-Yi, Gerber Anthony N, Zelarney Pearlanne, Make Barry, Wechsler Michael E

机构信息

Department of Medicine, National Jewish Health, Denver, CO.

出版信息

Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.

DOI:10.1016/j.chest.2021.12.654

PMID:35016912

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8743857/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a9/8743857/2bcef6e2dc61/gr1_lrg.jpg

相似文献

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis.慢性疾病中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗抗体反应受损：一项真实世界分析

Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对单剂SARS-CoV-2 mRNA疫苗的抗体反应。

Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析

Am J Respir Crit Care Med. 2022 Sep 1;206(5):644-648. doi: 10.1164/rccm.202203-0599LE.

Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应

Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.

Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.针对多发性硬化症患者的 SARS-CoV-2 灭活疫苗和 mRNA 疫苗的安全性和体液免疫应答率。

Mult Scler Relat Disord. 2022 Mar;59:103690. doi: 10.1016/j.msard.2022.103690. Epub 2022 Feb 13.

High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。

Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.

Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.BNT162b2 mRNA COVID-19 疫苗的抗体反应动力学：7 个月随访研究。

Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.

Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.实体器官移植受者完成mRNA SARS-CoV-2疫苗接种后体液免疫反应不佳。

Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较

Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.

Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?对常规抗病毒疫苗的抗体反应不理想的个体能否从 SARS-CoV-2 mRNA 疫苗接种中获得足够的抗体？

Viruses. 2022 May 3;14(5):956. doi: 10.3390/v14050956.

引用本文的文献

Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.对接种新冠疫苗的特发性肺纤维化患者免疫活性的综合分析。

Front Immunol. 2025 Jan 8;15:1436491. doi: 10.3389/fimmu.2024.1436491. eCollection 2024.

Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States.二价（原始毒株/奥密克戎BA.4/BA.5）mRNA新冠疫苗mRNA-1273.222与BNT162b2二价疫苗在美国有基础疾病成年人中的比较效果

Vaccines (Basel). 2024 Sep 27;12(10):1107. doi: 10.3390/vaccines12101107.

Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland.苏格兰接种疫苗后抗体反应与严重新冠病毒疾病结局之间的关联

NPJ Vaccines. 2024 Jun 14;9(1):107. doi: 10.1038/s41541-024-00898-w.

The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus.疫苗接种在 COPD 中的作用：流感、SARS-CoV-2、肺炎球菌、百日咳、呼吸道合胞病毒和水痘带状疱疹病毒。

Eur Respir Rev. 2023 Sep 6;32(169). doi: 10.1183/16000617.0034-2023. Print 2023 Sep 30.

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.慢性肺病患者中，疫苗引发的针对新冠病毒的B细胞和T细胞免疫功能受损。

ERJ Open Res. 2023 Oct 16;9(5). doi: 10.1183/23120541.00400-2023. eCollection 2023 Sep.

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.慢性肺病患者对新冠病毒的疫苗诱导B细胞和T细胞免疫受损。

medRxiv. 2023 Jan 28:2023.01.25.23284971. doi: 10.1101/2023.01.25.23284971.

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study.接受 BNT162b2 SARS-CoV-2 疫苗接种的间质性肺疾病患者的体液反应：一项前瞻性队列研究。

Respir Res. 2022 Sep 1;23(1):226. doi: 10.1186/s12931-022-02155-x.

Antibody Response to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in COPD: A Cohort Study.慢性阻塞性肺疾病患者对严重急性呼吸综合征冠状病毒2疫苗接种的抗体反应：一项队列研究

Chronic Obstr Pulm Dis. 2022 Oct 26;9(4):591-595. doi: 10.15326/jcopdf.2022.0315.

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.8 个月内单次给予 casirivimab 和 imdevimab 预防 COVID-19 的疗效和安全性：一项随机、双盲、安慰剂对照试验。

Lancet Infect Dis. 2022 Oct;22(10):1444-1454. doi: 10.1016/S1473-3099(22)00416-9. Epub 2022 Jul 5.

Am J Respir Crit Care Med. 2022 Sep 1;206(5):644-648. doi: 10.1164/rccm.202203-0599LE.

本文引用的文献

Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.免疫抑制对SARS-CoV-2 mRNA疫苗免疫原性的影响：一项前瞻性队列研究。

Ann Intern Med. 2021 Nov;174(11):1572-1585. doi: 10.7326/M21-1757. Epub 2021 Aug 31.

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。

N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.

High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗的高抗体反应。

Ann Rheum Dis. 2021 Oct;80(10):1351-1352. doi: 10.1136/annrheumdis-2021-220656. Epub 2021 May 24.

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。

Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.

Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.利妥昔单抗而非其他抗风湿疗法，与风湿性疾病患者对SARS-CoV-2疫苗的血清学反应受损有关。

Ann Rheum Dis. 2021 Oct;80(10):1357-1359. doi: 10.1136/annrheumdis-2021-220604. Epub 2021 May 11.

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。

JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.SARS-CoV-2 的持久免疫控制和预防再感染的前景。

Nat Rev Immunol. 2021 Jun;21(6):395-404. doi: 10.1038/s41577-021-00550-x. Epub 2021 Apr 29.

COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis.慢性阻塞性肺疾病与新冠病毒病不良结局风险：一项系统评价与荟萃分析

EClinicalMedicine. 2021 Mar;33:100789. doi: 10.1016/j.eclinm.2021.100789. Epub 2021 Mar 18.

Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.吸入性和全身性皮质类固醇的使用与慢性肺部疾病患者 2019 年冠状病毒病（COVID-19）检测阳性的相关性。

Respir Med. 2021 Jan;176:106275. doi: 10.1016/j.rmed.2020.106275. Epub 2020 Nov 28.

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。

J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验